The Medtronic Foundation and Children's Heartlink Focus New Partnership on Health Equity for 10,000 Children and 10,000 Health Workers in Underserved Countries

  • The $2.5 Million USD Multi-Year Partnership Builds Capacity to Provide Pediatric Heart Surgery to 10,000 Children and Trains 10,000 Health Workers in Brazil , India , and China .
  • The Partnership Strengthens Hospital Capacity, Reduces Health Disparities in Access to Care, and Engages Medtronic Employees in Strategy, Medical Education, and Technology.

- As the World Health Organization spearheads a global campaign on equity this World Health Day, the Medtronic Foundation and Children's HeartLink (CHL) are announcing a $2.5 million three-year, outcomes-based partnership to address congenital heart disease in children with a focus on reducing disparities in access to care and quality patient outcomes, and meaningful employee engagement. This partnership continues a rich collaborative legacy across the organizations, and is made in honor of Omar Ishrak, former chairman and CEO, Medtronic and former board member of the Medtronic Foundation, a true champion of impact driven philanthropy focusing on the underserved.

"Every child with congenital heart disease deserves access to quality pediatric heart care," said Paurvi Bhatt , Medtronic Foundation president. "Together with Children's HeartLink, the Medtronic Foundation is in a unique position to mark World Health Day by ensuring more children get equitable care and have the opportunity to survive and thrive."

Worldwide, the leading cause of death from a noncommunicable disease before age 30 is congenital heart disease. 1 Ninety percent of children born with heart disease don't have access to the care they need, and most of those children live in low- and middle-income countries. 2

"We are especially proud because this partnership brings together both the financial resources from the Medtronic Foundation and the time and skills of our passionate Medtronic employees. Together, we can improve quality care and patient outcomes," said Geoff Martha , Medtronic chairman and CEO, and member, CHL board of directors.

"We are honored to partner with Medtronic Foundation and help thousands more children, and the impact of health worker training will be felt for generations to come," said Jackie Boucher , Children's HeartLink president. "This partnership gives 10,000 children the chance for a joyful childhood and the opportunity to lead productive adult lives."

Specifically, the partners aim to actively address inequities in congenital heart surgery access and outcomes over three years by:

  • Strengthening hospital capacity and training 10,000 health workers (pediatric surgeons, pediatric cardiologists, and nurses) to provide congenital heart disease surgery and quality outcomes for 10,000 children.
  • Supporting CHL's strategic growth and innovation, enabling the organization to scale in underserved countries – doubling its impact between 2025 and 2030 by adding five new partner hospitals over the next 3 years.
  • Reducing health disparities in access to care through a mixed method study with partner hospitals, revealing key differences by gender, income, and socioeconomic status of families, and developing site-specific equity dashboards to foster continuous quality improvement.
  • Tapping Medtronic employees' skills and talents in domains such as clinical and medical education and training, technology development, market access, data science, and analytics.

For more information on the partnership, view this video .

About Children's HeartLink
Children's HeartLink saves children's lives by transforming pediatric heart care in underserved parts of the world. For more information, please visit childrensheartlink.org .

About Medtronic Foundation
Medtronic plc is the sole funder of Medtronic Foundation, whose focus is on improving lives for underserved populations worldwide, as well as supporting communities in which Medtronic employees live and give. For more information, please visit medtronicfoundation.org .

1 Bennett JE, Stevens GA, Mathers CD, Bonita R, Rehm J, Kruk ME, et al. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. The Lancet. 2018 Sep;392(10152):1072–88
2 Tchervenkov, C. I., Jacobs, J. P., Bernier, P. L., Stellin, G., Kurosawa, H., et al. (2008) The improvement of care for paediatric and congenital cardiac disease across the world: a challenge for the World Society for Pediatric and Congenital Heart Surgery. Cardiol Young, 18(S2), 63-69

Contacts :




Elizabeth Costello

Jackie Boucher

Medtronic Foundation

Children's HeartLink

+1-612-940-7693

+1-612-209-2026

Medtronic Foundation

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/the-medtronic-foundation-and-childrens-heartlink-focus-new-partnership-on-health-equity-for-10-000-children-and-10-000-health-workers-in-underserved-countries-301263683.html

SOURCE Medtronic plc

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference

Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference

- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conference on Thursday, May 29, 2025 .

Geoff Martha , Medtronic chairman and chief executive officer, will make a formal presentation beginning at 11:00 a.m. EDT ( 10:00 a.m. CDT ). Immediately following the presentation, Martha will be joined by Thierry Piéton, Medtronic executive vice president and chief financial officer, to answer questions about the company.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase

Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase

Building momentum in key franchises including Pulsed Field Ablation, TAVR, Cardiac Rhythm Management, Diabetes, Spine, and Neuromodulation

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2025 (FY25), which ended April 25, 2025 .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
Medtronic announces intent to separate Diabetes business

Medtronic announces intent to separate Diabetes business

Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies

Leading, scaled, direct-to-consumer Diabetes business poised to become standalone company; only company with a complete ecosystem to address intensive insulin management

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones

Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones

  • FDA Breakthrough Device Designation Awarded to AVIM Therapy
  • FDA IDE Approved for Virtue SAB U.S. Pivotal Trial for Launch

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, "Orchestra BioMed" or the "Company"), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced financial results for the first quarter ended March 31, 2025, and provided a business update highlighting continued regulatory momentum, disciplined operational execution, and a strengthening clinical development pipeline.

Q1 2025 Highlights:

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025

Medtronic to announce financial results for its fourth quarter and full fiscal year 2025

- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2025 on Wednesday, May 21, 2025 . A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https:news.medtronic.com . The news release will include summary financial information for the company's fourth quarter and full fiscal year 2025, which ended on Friday, April 25, 2025 .

Medtronic will host a video webcast at 7:00 a.m. CDT on May 21, 2025 , to discuss results for its fourth quarter and full fiscal year 2025. The webcast can be accessed at https://investorrelations.medtronic.com .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women

New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women

Star Jones , award winning television personality & women's heart health advocate,   helps kick off heart health conversations this Mother's Day with the Medtronic 'Letter to My Mother' campaign

A new Medtronic-sponsored survey of women ages 30-50 reveals a significant gap in awareness and discussion around heart health among women and their mother-figures. Despite cardiovascular disease being the #1 killer of women in the U.S. many women are still unaware of the risk and the importance of heart health.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×